Source Search Page

drugtargetreview.com > article

Assay design for Alzheimer’s disease: key considerations and emerging trends

...’s Research UK Oxford Drug Discovery Institute.... ...detecting early-stage neurodegeneration might impact future drug discovery... ...Neurosciences By Dr Emma Murphy (Alzheimer’s Research UK Oxford Drug... ...Drug Discovery Institute Emma joined the Alzheimer’s Research UK...

drugtargetreview.com > news

Mini-colons reveal complex process of tumorigenesis ex vivo

...Scientists part of the Matthias Lütolf research group at EPFL have... ...tissues give rise to tumours that closely resemble those found in vivo... ..., Colorectal cancer Dr Matthias Lütolf (EPFL) By Ellen Capon (Drug... ...Target Review), Francesco Sergi-Lindell (PreTT) By Drug Target Review...

drugtargetreview.com > news

How tumours prevent formation of immune responses

...Molecular Immunology at TUM, and Professor Sebastian Kobold, Deputy... ...Director of the Department of Clinical Pharmacology at LMU Klinikum... ..., Immunotherapy, T cells By Dr Suresh Nair (Lehigh Valley Topper... ...Böttcher (TUM), Professor Sebastian Kobold (LMU) Cancer research...

drugtargetreview.com > article

Uncovering the genetic and cellular impacts of smoking

drugtargetreview.com > news

New single-cell lipidomics method may unlock cancer treatments

...Dr Johanna Von Gerichten, from the School of Chemistry and Chemical... ...Engineering at the University of Surrey, explained: “The trouble... ...), Dr Johanna Von Gerichten (University of Surrey) Cancer Research... ...Dr Carla Newman, Associate Director, Cellular Imaging and Dynamics...

drugtargetreview.com > news

New findings regarding diabetes risk in childhood cancer survivors

...Researchers at St. Jude... ...Children’s Research Hospital have identified four previously... ...Children’s Research Hospital Related peopleDr Yadav Sapkota (St.... ..., Type-2 diabetes St Jude Children’s Research Hospital By Drug Target...

drugtargetreview.com > news

Exploring the role of class IIa HDACs in inflammatory diseases

drugtargetreview.com > news

Targeting RAS to overcome FLT3 AML drug resistance

..., the Institute of Cancer Research (ICR), Newcastle University, the... ...Princess Maxima Centre of Pediatric Oncology and the University... ..., Newcastle University, Princess Maxima Centre of Pediatric Oncology... ...Constanze Bonifer (University of Birmingham), Dr Terry Rabbitts (...

drugtargetreview.com > article

Developing the next generation of antibody drug conjugates

...In this Q&A, Léo Marx, Medicinal Chemistry Project Manager at Debiopharm... ...of high drug-to-antibody ratio (DAR) ADCs, with some achieving up... ...(Sibyla Biotech) By Ellen Capon (Drug Target Review), Francesco... ...By Ellen Capon (Drug Target Review), Léo Marx (Debiopharm) By Drug...

drugtargetreview.com > article

Women in Stem with Lidia Pieri

...In the STEM area, I was born as a physicist, which was – among many... ...After ten years of exciting postdoctoral research around Europe in... ...And so, I have been the managerial co-founder and CEO of Sibylla... ...Over the years, I came to perform in Buenos Aires and created a cross-cultural...